Insider Transactions in Q2 2025 at Insmed Inc (INSM)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
99,172
-13.36%
|
$9,222,996
$93.88 P/Share
|
|
Jun 11
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+27.07%
|
$910,000
$13.91 P/Share
|
|
Jun 11
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,423
-18.94%
|
$1,825,762
$94.5 P/Share
|
|
Jun 11
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,423
+15.93%
|
$330,191
$17.07 P/Share
|
|
Jun 10
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
38,300
-24.41%
|
$3,370,400
$88.64 P/Share
|
|
Jun 10
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,300
+19.62%
|
$651,100
$17.16 P/Share
|
|
Jun 10
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,740
-23.65%
|
$2,265,120
$88.64 P/Share
|
|
Jun 10
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,740
+19.12%
|
$669,240
$26.46 P/Share
|
|
Jun 10
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
57,766
-7.0%
|
$5,141,174
$89.47 P/Share
|
|
Jun 10
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,890
+13.89%
|
$862,020
$18.01 P/Share
|
|
Jun 05
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,879
-2.7%
|
$137,167
$73.5 P/Share
|
|
Jun 04
2025
|
David W J Mcgirr Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.98%
|
$219,000
$73.27 P/Share
|
|
Jun 03
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,579
-1.37%
|
$112,109
$71.5 P/Share
|
|
Jun 03
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,860
-1.3%
|
$132,060
$71.5 P/Share
|
|
Jun 03
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,686
-1.99%
|
$119,706
$71.5 P/Share
|
|
Jun 03
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,448
-2.04%
|
$102,808
$71.5 P/Share
|
|
Jun 03
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,472
-1.74%
|
$388,512
$71.5 P/Share
|
|
Jun 03
2025
|
David W J Mcgirr Director |
SELL
Open market or private sale
|
Direct |
3,250
-3.13%
|
$230,750
$71.3 P/Share
|
|
Jun 03
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,642
-1.37%
|
$116,582
$71.5 P/Share
|
|
Jun 02
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$484,930
$71.17 P/Share
|
|
Jun 02
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
May 30
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
26,327
-14.23%
|
$1,816,563
$69.28 P/Share
|
|
May 27
2025
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
200
-0.07%
|
-
|
|
May 21
2025
|
Clarissa Desjardins Director |
BUY
Open market or private purchase
|
Indirect |
1,130
+27.2%
|
$74,580
$66.35 P/Share
|
|
May 20
2025
|
Clarissa Desjardins Director |
BUY
Open market or private purchase
|
Indirect |
1,895
+50.0%
|
$125,070
$66.87 P/Share
|
|
May 20
2025
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
400
+50.0%
|
-
|
|
May 20
2025
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
400
-0.13%
|
-
|
|
May 20
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$457,610
$67.86 P/Share
|
|
May 20
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
May 20
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
21,057
-2.14%
|
$1,410,819
$67.77 P/Share
|
|
May 16
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,799
-2.08%
|
$120,533
$67.53 P/Share
|
|
May 15
2025
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,578
+5.42%
|
-
|
|
May 15
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,925
-10.28%
|
$645,125
$65.47 P/Share
|
|
May 15
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,508
+6.32%
|
-
|
|
May 15
2025
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,314
+6.24%
|
-
|
|
May 15
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,578
+4.43%
|
-
|
|
May 15
2025
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,508
+4.35%
|
-
|
|
May 15
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,508
+5.36%
|
-
|
|
May 15
2025
|
Leo Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+3.75%
|
-
|
|
May 15
2025
|
David W J Mcgirr Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+4.64%
|
-
|
|
May 15
2025
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+6.42%
|
-
|
|
May 15
2025
|
Melvin Md Sharoky Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+1.65%
|
-
|
|
May 15
2025
|
Clarissa Desjardins Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+7.02%
|
-
|
|
May 15
2025
|
Carol Schafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+7.4%
|
-
|
|
May 15
2025
|
David R Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+3.83%
|
-
|
|
May 14
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,236
-1.07%
|
$80,340
$65.61 P/Share
|
|
May 14
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
409
-0.44%
|
$26,585
$65.61 P/Share
|
|
May 14
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,744
-1.9%
|
$113,360
$65.61 P/Share
|
|
May 14
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,771
-1.19%
|
$245,115
$65.61 P/Share
|
|
May 14
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,925
-1.39%
|
$125,125
$65.61 P/Share
|